24 November 2021 : Clinical Research
Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1): A Novel Predictor for Recurrence of Hepatocellular Carcinoma After Curative Resection
Meng Xu1CDEFG, Chenghao Cui1AB*DOI: 10.12659/MSM.933109
Med Sci Monit 2021; 27:e933109

Figure 2 Increased DDR1 in serum and in tumors was associated with poor outcome of HCC patients. (A) HCC patients with high expression of DDR1 trended to have high possibility of recurrence and metastasis. (B) ROC analysis of different variables for predicting recurrence (B1) and AUC (B2).